European Medicines Agency / US Food and Drug Administration joint GMP inspection pilot programme. General principles

Author (Corporate)
Publisher
Publication Date 2010
Content Type

The purpose of this document is 'to provide advice to applicants and describe the policies and procedures to be used by the European Medicines Agency (EMA) and the US Food and Drug Administration (US FDA) on the coordination and performance of joint EMA/US FDA GMP inspections.'
Source Link Link to Main Source http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/11/WC500098836.pdf
Related Links
EMA: News, 11.8.10: EMA and US FDA seek potential candidate companies for joint GMP inspection programme http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/08/news_detail_001102.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp&jsenabled=true
Website: United States Food and Drug Administration http://www.fda.gov/
EMA/FDA: EMA / FDA joint GMP inspection pilot programme: Terms of reference and procedures for participating authorities (manufacturers of medicinal products) http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/11/WC500098837.pdf
Subject Categories
Countries / Regions ,